As many as 80% of sepsis deaths could be prevented with rapid diagnosis and treatment.
At our core is a team of highly accomplished, aspiring entrepreneurial scientists, engineers and clinical key opinion leaders with a clear focus to address unmet clinical needs, such as empowering an ICU Consultant to rapidly detect infection in a seriously ill patient.
In collaboration with clinicians, business experts and manufacturers, we have created a powerful microfluidic device that can address the specific unmet clinical needs as expressed by our network of clinicians not just the latest market reports!
We are currently completing clinical device validation using sepsis patient samples in collaboration with two Dublin based hospital locations and are determinedly working to accelerate the SepTec device to the next stage of commercialization.
Whether we are in the lab, at meetings with potential investors or we’re out in the world trying to sell our idea, we are passionate about what we do and what we are aiming to achieve!